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Abstract
Membrane receptors for neuromodulators (NM) are highly regulated in their distri-
bution and efficacy - a phenomenon which influences the individual cell’s response
to central signals of NM release. Even though NM receptor regulation is implicated
in the pharmacological action of many drugs, and is also known to be influenced by
various environmental factors, its functional consequences and modes of action are
not well understood. In this paper we summarize relevant experimental evidence
on NM receptor regulation (specifically dopamine D1 and D2 receptors) in order to
explore its significance for neural and synaptic plasticity. We identify the relevant
components of NM receptor regulation (receptor phosphorylation, receptor traffick-
ing and sensitization of second-messenger pathways) gained from studies on cultured
cells. Key principles in the regulation and control of short-term plasticity (sensiti-
zation) are identified, and a model is presented which employs direct and indirect
feedback regulation of receptor efficacy. We also discuss long-term plasticity which
involves shifts in receptor sensitivity and loss of responsivity to NM signals. Finally,
we discuss the implications of NM receptor regulation for models of brain plasticity
and memorization. We emphasize that a realistic model of brain plasticity will have
to go beyond Hebbian models of long-term potentiation and depression. Plasticity
in the distribution and efficacy of NM receptors may provide another important
source of functional plasticity with implications for learning and memory.
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neural signal transmission, learning, sensitization, dopamine, metaplasticity, LTP,
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1 Introduction
G-protein coupled receptors (GPCRs) which comprise a major group of cel-
lular receptors on many types of cells, including neurons, undergo significant
plasticity.
GPCRs become desensitized (phosphorylated) as a form of short-term plastic-
ity, which means that receptors are temporarily uncoupled from their effectors
(G-proteins). They also become down- or upregulated in a more lasting form
of plasticity, which involves receptor trafficking between intracellular stores
and the cell membrane, and in some cases receptor degradation as well as new
protein synthesis. These processes affect receptors for the main neuromodula-
tors serotonin, dopamine, noradrenaline and acetylcholine, for neuropeptides
such as opioids, for neurohormones such as steroids or estrogen, as well as the
metabotropic glutamate (mGLU) and GABAB receptors in the brain.
In general, receptors are sensitized and desensitized in response to agonist
exposure, modulated by cell internal parameters and synaptic activation. Im-
portant parameters for receptor plasticity are cell-internal calcium, and the
second-messenger dependent protein kinases A and C (PKA and PKC), as
well as G-protein specific kinases (GRKs). The time-scale of these changes is
within minutes for desensitization and several hours for alterations in receptor
distribution, which is comparable to ’early’ and ’late’ long-term potentiation.
The functional significance of this adaptive regulation is at present not well
understood. Receptor regulation has mainly be studied in response to vari-
ous pharmacological agents (antipsychotics, antidepressants, drugs of abuse),
where sensitization of NM responses has consistently been shown in different
tissues and cell types (e.g. ventral tegemental area and nucleus accumbens)
(1; 2). Behavioral effects of stress (3), learning (inhibitory avoidance, (4; 5; 6)),
and environment (novelty, social conditions) have also been documented (7; 8).
This evidence which points at an experience-dependent regulation of NM re-
ceptors coexists with a significant body of data showing constitutive expres-
sion of receptors to different types of neurons. The level of receptor expres-
sion varies for projection neurons (cortical pyramidal cells or striatal medium
spiny projection neurons) vs. local interneurons (fast-spiking vs. regular spik-
ing neurons) (9; 10), for different cortical layers or for patches in amygdala
or striatum (5), according to neuropeptide colocalization (e.g., substance P,
enkephalin) (11), and for neurons with a different connectivity (striato-nigral
vs. striato-pallidal neurons) (12). There is also developmental regulation of
receptor expression which is different postnatally (13; 14), during adolescence
(15; 16), as well as during ageing (17).
Constitutive receptor distribution sets the boundaries within which experien-
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ce-dependent fluctuations occur. These fluctuations may be transient or they
may have a permanent component corresponding to short-term desensitization
and long-term down- or up-regulation. In this paper we provide an overview
of the biological mechanisms involved in NM receptor regulation with the goal
of analyzing the adaptive function of this process. We will find that receptor
efficacy undergoes significant changes that are important in mediating neu-
romodulatory signals. We will also find that the regulatory processes under-
lying receptor plasticity are partly overlapping with the processes underlying
LTP/LTD.
We suggest that NM receptor regulation is a process which has the capacity
to contribute to brain plasticity on the population level, on the level of the
individual neuron and probably also on the level of the synapse. This provides
a mechanism for memorization and an added storage capacity beyond Hebbian
long-term potentiation and long-term depression. A better insight into the role
of NM receptor regulation may lead to a new understanding of brain plasticity
and a thorough revision of current theories of memory and learning.
2 Protein Regulatory Networks Underlying Receptor Plasticity
2.1 Component processes of receptor regulation
The molecular biology of receptor regulation has been elucidated in consider-
able detail, mostly by studies on cultured cells stably transfected with recep-
tors at fixed concentrations.
A number of different components have been identified:
(1) conformational change of receptor protein and functional uncoupling from
effectors (G-proteins) by phosphorylation.
(2) translocation of receptors from the membrane to a cytoplasmic structure
(in endoplasmic reticulum and Golgi apparatus) (receptor internaliza-
tion).
(3) reduction in potency and efficacy of a receptor in inducing changes in
second-messenger concentration (adenylyl cyclase, cAMP) (desensiti-
zation).
(4) receptor degradation in lysosomes, which removes receptor proteins
from the cytoplasma as well as the plasma membrane.
(5) translocation from a pool of internally stored receptors to the membrane
(recruitment, resensitization).
(6) delivery of newly synthesized receptors to the membrane (protein syn-
thesis).
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This shows that receptor regulation is far from being a simple process, as
might be expected if homeostatic regulation by feedback control were its only
function. Rather, the ”layering” of several processes indicates that both short-
term and long-term regulation of receptors occurs and that different ”entry-
points” for interacting processes exist to influence the outcome of a specific
stage in receptor regulation.
The prototype case for GPCR regulation has been the regulation of the β-
adrenergic receptor (18; 19), but the processes involved are somewhat different
for each individual GPCR type. We focus here on the dopamine D1 receptor,
which is also well documented, and which is of considerable significance in the
regulation of membrane excitability and neural signal transmission.
2.2 Protein regulatory network
The specific proteins and signalling substances involved in receptor regulation
are shown as a regulatory network for the dopamine D1 receptor in Fig. 1.
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Fig. 1. D1 receptor effectors and regulators: dark shaded, membrane receptors and
ion channels, light shaded, intracellular pathways. Possible dimerization D1-NMDA
is shown. Note the direct feedback regulation via PKA, also via RGS, GRK and the
indirect regulation via calcium, GRK. Possible interactive effects between cAMP
and Ca are also shown.
Functional D1 receptors are coupled to G-proteins, which form heterotrimer-
ic complexes. When receptors become activated, the coupled G-proteins dis-
solve into two components: Gα and Gβγ. These components have the ability
to modulate a number of membrane ion channels, such as inwardly rectify-
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ing K+ channels (e.g. GIRK channels) (20), Ih and other K+ channels (21),
high-voltage gated calcium channels (L-type, P/Q/R-type and N-type calcium
channels) (22; 23), and also sodium channels (24; 25). D1 receptors further-
more have the effect of increasing NMDA transmission (26; 27), and may have
complex effects on local calcium levels (28).
D1 receptors communicate with cell-internal pathways by activating Golf -
proteins (29), which raise adenylyl cyclase and cAMP-levels. cAMP-levels and
calcium levels are required for the activation of the transcription factor CREB
and the ’early genes’ fos and delta-fosB. Both proteins regulate the transla-
tional activity of mRNA and are critically involved in new protein synthesis.
D1 receptor coupling is reduced by protein kinases - both cAMP-dependent
kinase PKA and G-protein specific kinases (GRKs) (18; 30). These kinases
phosphorylate the receptor protein and contribute to the desensitization of its
effect on second messengers. Calcium indirectly reduces desensitization, via
the calcium-dependent protein calmodulin, which inhibits GRKs (31). Anoth-
er pathway for calcium to prevent desensitization has recently been detected
in the calcium sensor NCS-1, which reduces phosphorylation and internal-
ization of the D2 receptor (32). Arrestins can increase the effects of GRKs,
for instance, overexpression of arrestins reduces the ability of β-adrenergic
receptors to activate GS by > 75% (33). They play a major role in the inter-
nalization of receptors.
Desensitization is furthermore influenced by RGS-proteins, which regulate G-
proteins and G-protein signaling by activating GTPase (34; 35; 36). GTPase
is the kinase which phosphorylates G-proteins, and renders them insensitive
to receptor activation. RGS proteins take part in producing fast kinetics in
vivo by favoring reformation of the heterotrimeric state (Gα + Gβγ), while
the hydrolysis of GTPase is 40-fold slower in the absence of RGS (34). The
effect of overexpression of RGS proteins is a change in kinetic rate, an accel-
eration of the desensitization-resensitization cycle and also a net decrease of
desensitization. RGS levels themselves may become upregulated by dopamine
D1 and D2 activation e.g. in striatum, specifically RGS-2 and RGS-4 seem to
be enhanced by D1 or D2 receptor activation respectively (37; 38).
3 Short-Term Desensitization of Receptors
3.1 Receptor phosphorylation and desensitization of second-messenger acti-
vation
Receptor efficacy in general is determined by the amount of functional coupling
of an agonist and the reactivity of effector pathways.
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Receptor phosphorylation and internalization affect signal transduction by
agonist binding as a form of short-term variation. Membrane receptors undergo
functional decoupling by phosphorylation at multiple Ser and Thr residues,
which induces conformational change of the protein and prevents effective
ligand binding (39; 40). Phosphorylation is fast, with a half-time of less than
a minute for the D1 receptor and it is also reversible upon agonist removal
with a half-time for resensitization of about 10-15 minutes for the D1-receptor
(41; 42), cf. (43).
Phosphorylation and internalization may be achieved by PKA, which is cAMP-
dependent, or by GRKs, which are subject to regulation by calcium via calmod-
ulin or NCS-1 (44; 45; 46). Calcium may enhance receptor efficacy, when in-
tracellular calcium binds to calmodulin, and inhibits GRKs, e.g. GRK5 (46).
Interestingly, there may be another, ”corrective”, pathway for a direct inter-
action between calcium and GRK: the inhibition of GRKs by calmodulin can
be abolished by high levels of (calcium-dependent) protein kinase C (PKC)
(47). In general, overexpression of GRKs leads to reduced functional coupling
and requires more agonist to achieve the same amount of effect on second
messengers (subsensitivity) (48; 49; 50).
The role of PKA in phosphorylation of the D1 receptor is to a certain degree
controversial (51). There is indirect evidence from cell lines with reduced PKA
activity where desensitization is attenuated (52), and from mutant receptors
which lack a PKA phosphorylation site, where the onset time of desensitization
is greatly reduced (39). Also, (53) and (54) show that stimulating PKA can
mimic agonist-dependent desensitization. But there are also data by (55; 56),
which seem to indicate that PKA is not important in desensitization. The
work by (40) (based on a PKA-insensitive mutant receptor) suggests that
PKA has a major effect on receptor trafficking within the cell and increases
proteolysis, but is not strictly required for desensitization of cAMP. Thus it
has been suggested that PKA modifies a later process in desensitization, which
is more intimately linked to internalization and recycling probability, rather
than agonist-induced phosphorylation. In this sense, GRKs and PKA are most
effective at different stages of the desensitization process. This would also
imply a different time course of their feedback regulation, since PKA would
operate with a longer delay in its reduction of receptor efficacy.
3.2 Key factors in desensitization
When a receptor is in a phosphorylated state, it is effectively uncoupled from
its effectors, until it becomes dephosphorylated. For the dopamine D1 receptor,
both of these processes can be performed without internalizing the receptor.
However internalization is often the consequence of phosphorylation and both
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processes together may be termed ”desensitization”, since they affect the func-
tional efficacy of a receptor population in transmitting signals to intracellular
pathways.
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Fig. 2. Desensitization of the cAMP pathway for the D1 receptor. Data have been
combined from (57), (41) and (55). The sigmoid shape of the dose-response rela-
tionship is clearly evident in the vertical axis. Length of pretreatment in contrast
seems to follow a logarithmic curve. The reduction of efficacy can reach up to 80%.
To study the desensitization mechanism for a given receptor, receptors are
overexpressed in cultured cells, and then exposed to agonists at different con-
centrations and for different times. The amount of functional coupling is as-
sessed by measuring concentrations of adenylyl cyclase or cAMP. These ex-
periments have shown that functional efficacy strongly depends on the level
of agonist exposure.
Fig. 2, 3 show the time course of desensitization by measuring the concentra-
tion of adenylyl cyclase and cAMP. In Fig. 2 data from (57), (41) and (55)
are combined. The desensitization of the D1 receptor reduces the ability of a
brief dopamine challenge to enhance adenylyl cyclase and cAMP-levels. This
desensitization is both dose-dependent and dependent on pretreatment time.
Dose-dependence follows a sigmoidal shape, with a critical range between 10−6
and 10−7 mol dopamine. Pretreatment time does not increase desensitization
much beyond an initial effect. Overall, there is a reduction in receptor efficacy
of up to 80%.
Fig. 3 shows similar data from the desensitization of the D2 receptor (58). The
D2 receptor has the capacity to inhibit the adenylyl cyclase/cAMP pathway
and this capacity is reduced by agonist-dependent desensitization only up
to 20%. The critical range of agonist exposure, however, is similar. Again,
7
0
50
100
150
200
250
300
350
−9
−8
−7
−6
−5
−4
50
60
70
80
90
100
AC
 in
hi
bi
tio
n 
(in
 %
)
agonist exposure (10e−x M DA)
pretreatment time (m)
Fig. 3. Desensitization of adenylyl cyclase(AC) inhibition for the D2 receptor. Data
are taken from (58). Possibly sigmoidal and logarithmic shapes of the curves are less
evident, probably as a result of the limited data set. The effect of desensitization is
limited to about 20%.
pretreatment time (here up to 6 h) is not a strong factor.
We can derive a general functional form for receptor efficacy (C) which reflects
the dependence on agonist stimulation (A):
C =
1
1 + e−A
. (1)
The amount of agonist stimulation can be described by an integral over the
NM concentration:
A =
∫
NMtdt. (2)
The sigmoidal shape of the function reflects the fact that receptor efficacy is
almost linearly dependent on agonist exposure within a certain concentration
range and reaches saturation or stays below a threshold otherwise. This is
visualized in Fig. 4. Furthermore, Fig. 4 shows the modification of this basic
shape by additional parameters (s. below).
It may well be that receptor desensitization depends on the particular time
course of agonist exposure rather than the total amount. These experiments,
though technically feasible, have not systematically been carried out. For in-
stance, phasic increases of NM concentrations which are short-lasting may fail
to desensitize receptors significantly, while tonic increases with a smaller to-
tal amount of agonist stimulation may have a larger effect. However, in the
absence of experimental data, integrating over agonist concentrations in time
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seems to be the best approximation. Further work may allow to refine the
formula in eq. 2 to incorporate different temporal patterns of agonist stimu-
lation.
This basic agonist-dependent desensitization may be modified by a number of
factors. First of all, as we have seen, there are several cell-internal parameters
which influence the magnitude of desensitization. For instance, a high level of
GRKs shifts the agonist-dependence curve to the right (48; 49; 50). A basic
parameter I1 allows to express sub- and supersensitivity of receptors, defined
by dose-dependence of agonist exposure:
C =
1
1 + e−A+I1
. (3)
Presumably, the amount of phosphorylation by protein kinases can be ex-
pressed with this parameter. Experimental data show that I1 can be ma-
nipulated by overexpression of GRK (50). We’d similarly expect increased
calcium/calmodulin to have an effect on this parameter.
The action of RGS proteins is different in that it has a significant effect on the
resensitization dynamics. Receptors prompt conversion of the inactive G pro-
tein to an active form. RGS proteins accelerate the conversion of the activated
G protein back to its inactivated form (35; 36). Several studies have shown
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(59; 34) that reduced RGS activity leads to significantly less receptor efficacy
both in terms of slow onset and prolonged recovery times, measured by N-
type calcium channel or GIRK channel activity (see Fig. 5). In contrast, high
RGS levels lead to fast recovery and may reduce onset of receptor activation
(60; 61; 62; 63).
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Fig. 5. Desensitization dynamics modulated by RGS-proteins. The functional shape
is adapted from (34) and (60), according to alterations in the half recovery time t0.5
and the rise time trise.
Thus RGS proteins speed up resensitization and affect receptor efficacy inde-
pendent of agonist levels. This effect can be expressed by a parameter I2:
C =
1
1 + e
−A+I1
I2
. (4)
Finally, desensitization depends on the amount of time a receptor exists in
the functional conformational state. Receptors may exhibit a high degree of
spontaneous conformational change, which means that they become activated
even in the absence of agonist binding. For dopamine receptors, D5 receptors,
which are similar to D1 receptors, have a high degree of this constitutive
activity (64), cf. (65; 66). This can be expressed by a factor for desensitization
(λ) which is constitutive for each receptor type.
C = λ
1
1 + e
−A+I1
I2
. (5)
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Receptor efficacy as measured by effects on cAMP/adenylyl cyclase need not
be identical to effects on membrane ion channels and consequently neural
transmission. But in general, dopamine D1 mediated effects on membrane ex-
citability can be mimicked by forskolin-mediated stimulation of PKA, impli-
cating the cAMP-pathway as the major factor in regulating membrane prop-
erties. The cAMP/adenylyl cyclase pathway thus provides an important state
parameter for the regulation of protein phosphorylation, the expression level
of protein kinases and a common pathway for a number of G-protein coupled
receptors. Strictly synaptic components of receptor activation (NMDA channel
regulation and presynaptic regulation of transmitter release), however, may be
regulated by other pathways, with prominent dependence on calcium and pro-
tein kinase C levels. The cAMP-pathway also influences early gene expression
(c-fos, delta-fosB, CREB), which are important variables for protein synthesis
and any functional cell plasticity that is regulated in the long-term. Thus we
can regard regulation of the cAMP pathway as a basic mechanism that may
affect receptor efficacy for both membrane excitability and gene expression/
protein synthesis (cf. (67; 41)). The relation between receptor efficacy and
synaptic modulation may be regulated in a somewhat different way.
We have seen that the efficacy of the D1 receptor in raising intracellular cAMP-
levels depends on the influence of different factors on the desensitization func-
tion.
Three different types of parameter (λ, I1, I2) can be distinguished by their
influence on receptor efficacy (see Fig. 4).
I1 shifts the function to the left or right without affecting its shape, corre-
sponding to an alteration of the dose-response relationship.
I2 alters the steepness of the function and thus the temporal properties of
receptor desensitization.
λ flattens the curve indicating less dependence on agonist stimulation.
This basic variability of receptor efficacy emerges from the parametrization
of the functional form. Parameter fitting to experimental data may allow a
further quantitative analysis of these functional relations.
3.3 Feedback loops in regulating receptor efficacy
In this section, we will outline a model for the dynamic interactions that de-
termine receptor efficacy. We will develop a qualitative approach that demon-
strates the emergence of bistability in receptor efficacy - understood here as
a stable state which results from a prolongation of the cellular response be-
yond the actual duration of the signal. In a slightly different sense, bistability
emerges when there are trigger signals both to induce a new state and to turn
11
VPKA = α1 IPKA + β1 VNM
VRGS = α4 IRGS + β4 VNM
VCa = α3ICa + β3 VNM
VGRK = α2IGRK − β2 VCa
I1 = −γ1 VPKA − γ2 VGRK + γ3VRGS
I2 = γ4VRGS
A =
∑
t=0 INM
C = 1/(1 + e(−A+I1) 1/I2)
VNM = C INM
Table 1
A system of equations defines a simulation model for the regulation of receptor
efficacy C. Concentrations for PKA, Ca and RGS (Vx) are determined by an inde-
pendent component Ix and by feedback from the receptor activation VNM . GRK is
determined by IGRK and the calcium level VCa. λ is regarded as a fixed parameter
for the D1 receptor. The actual receptor activation VNM is modeled as a product
of agonist concentration and receptor efficacy.
it off (cf. (68; 69; 70) for discussions of bistability and multistability in this
context), and as we shall see this condition is probably also met. The model
is purely qualitative, an attempt to illustrate the conditions that might un-
derlie a short-term regulation of receptor efficacy that provides an important
physiological state parameter for understanding the computational properties
of neuromodulation. But a full numerical model, e.g. based on chemical mass-
action models (71; 72) could be developed on the basis of this approach and
would allow more detailed investigations of these interactions.
The model determines the parameters I1 and I2 in eq. 5 from kinase activity
(I1) and RGS-level (I2). The protein regulatory interactions that determine
the parameters I1 and I2 in this model are described by a number of equations
as shown in Table 1. Each of the concentrations in the model is calculated from
a component that is independent of feedback within the system (ICa, IPKA,
IGRK and IRGS), and a component that depends on the activation of the re-
ceptor (VNM). GRK levels specifically are influenced by indirect feedback via
calcium levels - which provides an entry-point for a more complex regulation
of GRK levels by other processes affecting calcium. The ratio between these
components is determined by the factors αi and βi. This analytical approach
of separating system-internal components from outside influences has clear ad-
vantages in model construction and control over system components and also
enables modular construction with clearly defined interfaces which is lacking
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in more ’bottom-up’ approaches to intracellular modeling (72; 73).
However, it is assumed that the effect of the receptor activation VNM on the
concentration is only linear - raising or lowering levels by an amount propor-
tional to VNM . This is a simplifying assumption that may have to be examined
in further work.
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Fig. 6. The diagram shows the dependencies between the concentrations for the
kinases GRK and PKA, for calcium, and the role of RGS proteins. The factors αi,
βi and γi are shown as labels on the links between parameters.
Fig. 6 visualizes the relations between the parameters. The target regulated
value is the receptor efficacy C. The actual receptor activation effect VNM is
defined by both the efficacy C and the current agonist stimulation INM . The
main parameters I1 and I2 are defined by concentrations of the kinases PKA
and GRK (VPKA and VGRK), and the levels of RGS-proteins (VRGS). Specif-
ically, I1, which determines the right- or left shift of the dose-response curve
for the receptor, is assumed to be a linear combination of the concentrations
for the two kinases. Since these kinases may act with different time courses,
a more complex interaction may have to be empirically determined by more
detailed experimental work.
C is being set by the agonist exposure summed over time, and indirectly by
the PKA, GRK and RGS levels. There is also some experimental evidence
concerning the free parameters αi, βi and γi in the system. For instance, the
ratio β1/α1 should be larger than β3/α3. This is the case, since the contribution
of D1 receptor activation to PKA levels is probably much higher than its
contribution to calcium levels (28; 57; 41; 55). Also, γ2 > γ1, since GRK
seems to have a stronger effect than PKA on receptor regulation (see above,
section 3.1).
With this system we arrive at a simplified, but functional model for the com-
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putation of receptor activation, taking the internal state of the neuron, defined
by protein and calcium concentrations, into account. Further work is needed
to more fully develop such a model as a basis for empirical predictions and in
close correspondence with ongoing experimental work (cf. (72) for an example
of such experimental validation).
However, even the basic model can be employed to illustrate the emergence
of a limited form of bistability, which may provide an important prerequisite
for functional long-term plasticity as memory for brief signals to appear.
Receptor efficacy undergoes both negative (cAMP-dependent) and positive
(calcium-dependent, RGS-mediated) feedback. There are two main regulatory
loops, the PKA/PKC-mediated and GRK-mediated feedback. PKA/PKC are
up-regulated by D1, and thus provides a negative feedback loop. GRK levels
are influenced by internal calcium and thus constitute a positive feedback loop.
In general negative feedback leads to oscillatory dynamics with appropriate
phase delays, while additional positive feedback can lead to the establishment
of multistability (74).
The presence of antagonistic feedback effects suggests bistability mediated
by calcium in the presence of slow oscillatory rhythms regulated by PKA. A
simulation of the system shows the emergence of these features. The graph in
Fig. 7 shows the induction and persistence of a state of high receptor efficacy
by two calcium spikes.
0 500 1000 1500 2000 2500 3000
time
   I−NM 
Ca 
PKA 
C 
V−NM 
Fig. 7. Calcium-induced multistability of receptor efficacy. This simulation uses the
model defined in Table 1, with a time delay for VPKA (α1IPKA+(β1VNM−delay))).
Brief triggering increases in calcium concentrations ICa induce changes in receptor
efficacy C maintained by positive feedback and switched off by delayed increase in
PKA-level. Actual receptor activation V-NM has different magnitudes for identical
signals INM .
In the first case, the increase in calcium precedes a neuromodulatory signal.
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Due to feedback effects, the increase in receptor efficacy C persists even when
the calcium signal is terminated. Accordingly, the response of the receptor to
this signal is increased compared to an agonist signal in the absence of calcium
(second signal). This model also shows a critical dependence of response on the
respective timing of Ca and INM signals, which should be testable empirically.
The existence of bistable or multistable states that persist beyond the dura-
tion of a trigger signal shows the realization of an important computational
principle, the equivalent of a flip-flop device. This is a basic memory element
and probably a necessary component for long-term plasticity of NM receptor
efficacy. The critical dependence of efficacy on relative timing of calcium and
NM signals opens up interesting perspectives for an interaction of NMDA and
D1 related signals.
4 Long-term Plasticity of Neuromodulatory Receptors
4.1 Receptor super- and subsensitivity
Besides the short-term processes of densensitization and resensitization, there
are also distinct processes of long-term regulation of NM receptor efficacy (75).
Long-term alterations in receptor efficacy for membrane-bound responses can
be measured directly by responsivity to agonist stimulation.
Both subsensitive and supersensitive populations of cells have been described
in various tissues. Dopamine D1 supersensitivity has been shown in stria-
tum after interruption of the dopaminergic nigro-striatal pathway (76) or in
genetically altered dopamine-deficient mice (77). Exposure and withdrawal
conditions for amphetamine or cocaine also change dopamine receptor sensi-
tivity. For instance, there is D1 receptor supersensitivity in nucleus accumbens
(78; 79; 80; 1; 81) and D2 receptor subsensitivity in nucleus accumbens (82; 79)
and ventral tegmental area (79). Treatment with antipsychotic medication has
also shown consistent shifts in receptor sensitivity in a number of brain areas
(ventral tegmental area, prefrontal cortex, basal ganglia)(83; 84; 85). Fur-
thermore, experiments after specific learning events such as socialization or
restraint stress have been reported to affect receptor density. For instance, D2
receptor binding density in striatum is increased for socially dominant mon-
keys and reduced for subordinate monkeys (7) and induction of overexpression
of D2 receptors in nucleus accumbens by genetic transfer in rats correlates with
an increased resilience to alcohol addiction (86). Alterations in density of mus-
carinic receptors in neocortex and amygdala have been observed as the result
of training in an inhibitory avoidance task (6; 87).
15
Receptor density can be indirectly assessed by the binding capacity of recep-
tors to radioligands (for membrane receptors) or the amount of mRNA for
a receptor (which comprises both internalized and membrane-bound receptor
protein). With brain imaging (PET/SPECT), radioligand binding can even
be measured in the living human brain (88; 89).
Similarly to short-term desensitization, receptor density tends to increase at
low concentrations of agonist and decrease at high levels of stimulation. For
instance, ongoing agonist stimulation (> 4h) has been shown to result in
long-term loss of membrane-bound receptor density for the dopamine D1 re-
ceptor in cultured cells (up to -50% of control with t1/2= 8h, (90)). This basic
homeostatic regulation is however embedded in a system of further regulatory
factors, which allow storage and permanence of receptor localization and den-
sity. Thus, long-term shifts in receptor density and efficacy may also be the
result of specific brief co-ordinated events that affect relevant parameters in a
sustained fashion. In this sense, long-term plasticity in receptor density may
have a memorization function that goes beyond adaptivity to current agonist
concentrations.
Another question is the relationship between receptor density and functional
receptor sensitivity. Often, receptor density is directly parallel to functional re-
ceptor sensitivity as measured by effects on membrane excitability or synaptic
transmission. Thus agonist depletion produces both an increase in receptor
density and an increase in electrophysiological responsiveness e.g. of beta-
adrenergic receptors in hippocampus and cortex (91) or for opioid receptors
after morphine withdrawal (92).
But increased sensitivity of a receptor may occur without an increase of recep-
tor density. The pharmacodynamic response to agonist occurs in proportion
to the quantity of the ternary complex agonist-receptor-G-protein, not just
receptor protein abundance per se, or even membrane-bound receptor protein
abundance (93; 94). Receptors can exist both in a state where they are coupled
to GTP-free G-proteins (high affinity to agonists), or they may exist without
the effector molecule G-protein coupled to it, the low affinity state (95). The
supply of G-proteins is restricted in cells, such that there is competition for
receptors to achieve a high affinity state. Experimental evidence has indicated
that there are shifts in affinity of D2 receptors in nucleus accumbens after
exposure to amphetamine, which can explain increases of D2-receptor medi-
ated behavior, even though the total receptor density remains unaltered (96).
In this case, D2 receptor supersensitivity is expressed by an increase in high
affinity (G-protein coupled) receptor sites (97).
This form of plasticity has certain implications. If we assume that receptor
localization on the cell membrane (i.e. at synaptic sites) is relevant for neural
transmission, changes in affinity can modulate transmission without affecting
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receptor localization. This may be important for the retention of the functional
properties of the modulated system.
Finally, long-term alterations of receptor sensitivity may be expressed by al-
terations in intracellular pathways, such as a permanent upregulation of the
cAMP-pathway (98). In this case the shift in sensitivity is not specific to
the type of receptor but to the pathway being modulated, which is usually
connected to a number of different receptors. Thus there is a third process
available to effect long-term changes in receptor efficacy.
Detailed experiments on dopamine receptor sensitivity have been conducted
in slices of rat brain after exposure to cocaine or amphetamine.
Sensitivity is here usually assessed by response threshold to different concen-
trations of agonist. For nucleus accumbens in cocaine-sensitized animals, a
much lower dose of dopamine (20µM) elicits a electrophysiological response
in D1 receptors than is required in control animals (75µM , (99)). The effect of
the higher dose (75µM) is the same in the supersensitive and normal system
(99). Thus there is a leftward shift in dose-dependence which is compatible
with a change in the I1 parameter for receptor efficacy (see eq. 4 above).
Alternatively, the normal response to NM modulation may become replaced
by an ongoing ”chronic” response and the cell becomes subsensitive or ceases
to be responsive to agonist stimulation. This form of whole-cell plasticity is
not dependent on neuromodulator receptors, but consists of a shift in the ion
channel distribution and density that defines membrane excitability (e.g. (100;
101)). For instance, in cocaine-sensitized animals, some cells constitutively
suppress the N- and P-type calcium channels that are normally suppressed by
D1 receptor activation (102). The effect is a loss of NM responsivity on this
parameter.
4.2 NM effects on neural transmission
The neural response is a product of both agonist concentration and the current
receptor efficacy. Previous computational models that attempted to assess the
function of neuromodulation on the basis of variable agonist concentrations
(103; 104), assuming that receptor response would be uniform in space and
time, may have failed to factor in the real receptor variability, which, as we
have seen, is highly regulated and therefore likely to be of functional impor-
tance rather than only a source of unreliability and error (’noise’).
Generally, neuromodulators have the potential to affect both synaptic trans-
mission and intrinsic (whole-neuron) membrane properties. The synaptic ef-
fects of the D1 receptor, and NM receptors in general, concern the regulation
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of transmitter release by presynaptic receptors and the regulation of NMDA-
mediated glutamatergic transmission by postsynaptic receptors (105).
Neuromodulators also have diffuse effects on the membrane potential of the
neuron, mediated by alterations in ion channel currents from receptors on the
dendrite and soma in postsynaptic and non-synaptic positions (106; 107). The
significance of whole-neuron modulation, however, is considerably less well
investigated as a source of memorization and learning.
There is a consensus that both presynaptic D1 (108; 109; 110; 111; 112; 113;
114) and D2 receptors (115; 116; 117; 118; 119) depress the amplitude of evoked
EPSP’s in a number of different tissues with some debate as to whether the
frequency of spontaneous EPSP’s is similarly reduced (120; 114) or actually
increased by presynaptic D1 receptors (121). A similar effect has been ob-
served for the regulation of GABA release: both D1 and D2 receptors reduce
evoked IPSP’s (122; 123; 20; 124; 125; 126; 127). In postsynaptic position
dopamine D1 receptors enhance NMDA transmission, by increasing peak con-
ductance and lowering the threshold voltage for NMDA receptor activation
(26; 128; 27; 129). There may also be an effect of dopamine D1 receptors on
AMPA receptors via phosphorylation of GluR1 subunits at Ser845, mediated
by inhibition of PP1 and PKA (via DARPP-32, (130)) in striatal neurons.
This conformational change increases the channel open time probability (in
contrast to phosphorylation at Ser831 by PKC and caMKII, which increases
AMPA channel conductance.) Thus dopamine may also be able to enhance
peak AMPA current in specific dopamine D1 receptor rich areas of the brain.
On the neuronal level, the effect of neuromodulators on signal transmission
is expressed by altering membrane excitability. However, it has been difficult
to assess these effects precisely with the help of in vitro slices, and there is
some disagreement concerning the effects of the dopamine D1 receptor. The
D1 receptor enhances or reduces the contribution of a number of ion channels,
such as high-voltage activated calcium channels (L-type calcium channels are
enhanced in neostriatal spiny neurons (22), N- and P-type calcium channels
are blocked (23)). It also affects sodium (25) and potassium channels (21).
The effects on neuronal firing patterns are obviously complex, since they de-
pend on membrane voltage, the distribution and frequency of different ion
channels and other events affecting ion channel currents.
4.3 Synapse- and cell-specific receptor regulation
We have seen that there is a significant body of evidence showing that NM
receptors undergo experience-dependent long-term plasticity.
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These results focus on the response of a population of neurons by examin-
ing a few selected neurons with the most pronounced alteration of response.
Results are usually not reported with an emphasis on cell-specific variability.
Nonetheless, there is often considerable heterogeneity with respect to reactivi-
ty to NM’s within a population of neurons in a slice (J. Seamans, pers. comm.,
for dopamine D1 and D2 receptors in deep-layer prefrontal cortical cells) with
’high responders’ and ’low responders’ within a neuronal population. Visual
inspection also shows a varying number of fluorescent-labeled receptors on
cultured cells, e.g. transfected with D2 receptors (131), which is understood
as an individual variability of receptor distribution and density (S. Rayport,
pers. comm.). Cellular binding patterns for dopamine receptors are different
for different neurons also in striatal slices (132),(133),(134). New techniques
of laser capture microscopy may be able to give clear answers on the question
of cell-specificity (M. Ariano, pers.comm).
There are also results indicating that receptor density may vary in ’patches’ of
(subcortical) tissue or microcolumns in cortical tissue (135). For instance, fear
conditioning influences muscarinic receptor density differentially in different
regions of the amygdala (87), (136).
Synapse-specific regulation has been shown conclusively in the short-term
(137). NM receptors in synaptic positions are also anchored by scaffolding
and anchoring proteins, which indicates that positioning of membrane recep-
tors at a specific site is relevant to NM receptor action (138; 139). Thus, the
basic mechanisms for synaptic long-term plasticity exist. Very recently, (140)
have actually shown direct synaptic plasticity at cholinergic synapses in hip-
pocampus.
4.4 Functional consequences of long-term plasticity
We have argued that the effects of neuromodulation on neural transmission
are not sufficiently described by the fluctuations in the concentration of ago-
nist, but require an analysis of receptor sensitivity as well. This means that
the responsivity of the cell as expressed by receptor density and efficacy will
determine the net effect on neural transmission.
The consequences of this regulation are somewhat different, whether we look at
this from the perspective of a homogeneous shift in sensitivity in a particular
brain area, or whether we assume cell-specific effects to be present under
physiological conditions.
Thus the plasticity located in the receptor and its internal transduction path-
way could be functionally significant at the level of the individual cell and the
synapse. This could be the case for both short-term and long-term plasticity.
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Fig. 8. Two expanded views on information storage in neural networks. A: Process-
ing units are linked by connections of differing strengths. Overloading and switching
allows fast modification of synaptic strengths. B: Processing units differ by their ac-
tivation of transfer function. Neurons with different membrane properties interact
in a ’heterogeneous’ network.
Long-term plasticity in the responsivity of neurons and synapses to a neu-
romodulatory signal implies a mechanism of information storage that is ex-
pressed by the placement of NM receptors leading to an individual cell signa-
ture. Thus, NM receptor plasticity adds a layer of storage capacity to neurons
and synapses which allows memorization other than through Hebbian process-
es (see Fig. 8). This hypothesis is considerably different from the widespread
assumption that neuromodulation influences a global parameter for neural
transmission which is uniform for all cells and synapses in a targeted brain
region (104; 141).
Synapse-specific regulation of NM receptor efficacy and distribution specifical-
ly adds an important dimension to traditional accounts of long-term potentia-
tion (LTP) and long-term depression (LTD), which focus on the contribution of
the glutamatergic pathway. It introduces additional variables which determine
the magnitude of change of glutamate synaptic transmission when presynaptic
NM receptors are activated and postsynaptic receptors interact with NMDA,
AMPA or GABAA receptors. A NM signal-gated change in synaptic ”weight”
reflects a synapse-specific fixed parameter (namely the presence, absence or
magnitude of a NM receptor mediated effect). The presence of a strong, pha-
sic increase of NM concentration will then result in ”fast synaptic switching”
(Fig. 8 A). This means that synaptic connections can be quickly and reversibly
set to a new weight, without interfering with any long-term properties of
the glutamate transmission. Technically, this corresponds to ”overloading” of
synaptic connections with several possible synaptic weights each of which can
be switched on by activation of appropriate NM receptors. Such mechanisms
have occasionally been suggested in order to add to the known capabilities of
neural networks (142; 143). In (144) it was shown that template switching by
neuromodulator control of presynaptic release is particularly amenable to the
idea of state-dependent task performance, which is a major biological function
of neuromodulation.
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4.5 Implications for brain plasticity
The idea that neuromodulation contributes to long-term potentiation and
long-term depression, influencing the magnitude of change in glutamatergic
transmission, has been around for a long time. A number of experimental re-
sults have been obtained that support a measurable difference for LTP/LTD
in the presence or absence of high levels of neuromodulators, such as dopamine
(145; 146). In this context, the theoretical concept of ’metaplasticity’ has been
developed (147), cf. (148). This concept assumes a level of regulation for glu-
tamatergic plasticity that is not dependent on Hebbian associativity of pre-
and postsynaptic firing (’meta’-level). Another idea that forms the basis of a
number of computational accounts of dopamine-related plasticity (149; 104)
is ’three-factor Hebbian plasticity’, i.e. regulation of glutamatergic signalling
strength that requires a ’third factor’, namely dopamine, in addition to concur-
rence of presynaptic and postsynaptic events. Both approaches, however, do
not challenge the idea of glutamatergic signalling as a ’final common pathway’
for different sources of plasticity and the changes in glutamatergic signalling
as the substrate for learning.
In contrast to that, we have aimed to show that there is a significant mo-
tivation from the perspective of molecular biology that receptor plasticity is
an ubiquitous phenomenon which may have become recruited for learning and
memorization for a number of different neurochemicals. We have also reported
here that there is convincing electrophysiological evidence that shifts in recep-
tor sensitivity do occur in the long-term, even though specificity for individual
cells and synapses is not well proven. The exact relationship of this form of
plasticity to physiological brain adaptivity is at present virtually unknown.
The effects of NM receptor activation on intrinsic properties of the neuron - ex-
pressed by membrane excitability and ion channel activation - add a significant
dimension to brain plasticity. The most prevalent view of neural plasticity as
altering the strength of connections between neurons is changed considerably,
when we accept whole-neuron adaptive plasticity (Fig. 8 B).
This role of whole-neuron plasticity within network processing has occasionally
been explored from a theoretical perspective (cf. (107; 150)). The alteration
of membrane properties due to neuromodulation or a specific composition
of ion channels induces a ’filter’ on signal transmission that may affect gain
modulation (151) or short-term retention of spike input patterns (152). A
significant difference in receptor density and sensitivity will affect the efficacy
of the intrinsic ’filter’ for each individual neuron.
NM receptor regulation is specifically interesting for its property of ’condi-
tional’ plasticity. This means that differences in parameter setting are greatly
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enhanced when a sufficient amount of agonist is present to engage NM recep-
tors. The functional implications of NM receptor plasticity will be virtually
non-existent or very strong depending on fluctuations in agonist concentration
or the presence of an agonist signal.
5 Conclusion
Even though the relevance of the biological processes underlying G-protein
coupled receptor regulation to addiction research and psychopharmacology is
frequently asserted (98), we still do not have a good understanding of the
physiological function of this form of plasticity.
The simplest theory would assert that receptor regulation is essentially a
homeostatic control mechanism to counteract the significant fluctuations in
agonist availability. In this scenario, the goal of receptor regulation is to en-
sure a target range of NM effectiveness.
Certainly that is a very important function of receptor regulation from a
metabolic perspective. But the presence of multiple, nested feedback loops
in a complex, highly regulated system suggests the presence of multistable
solutions. The presence of receptor anchoring adds the necessary stability to
transform transient fluctuations at synaptic sites into permanent values.
In this paper we have focussed on the hypothesis :
(a) that neural information processing is influenced by the combination of the
neurochemical signal (the agonist concentration) and the receptor response
(the receptor efficacy or sensitivity),
(b) that receptor efficacy is regulated on the level of the synapse and the
neuron, and
(c) that long-term plasticity of NM receptors is functionally significant in
information storage.
The regulation of agonist concentration is of course another important factor in
understanding neuromodulation. Even though short-term changes are mainly
a result of firing of the producer cells, transporter availability is another major
factor that undergoes a form of functional plasticity (153; 154; 155).
Other questions that require experimental analysis are the conditions that trig-
ger the transition from short-term to long-term plasticity and the behavioral
paradigms that influence long-term receptor density and placement. Certain-
ly, further experimental evidence is required to explore the validity of this
hypothesis.
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Another important conclusion of this work is that the role that NMDA activa-
tion, calcium influx and enhanced protein synthesis play in a large number of
behavioral learning experiments may have to be re-assessed without automat-
ic reference to the ’dogma’ of glutamatergic synaptic plasticity as the neural
substrate of learning and memory. In contrast, NMDA- and calcium- related
induction could point to a common, integrated perspective on neural plastic-
ity, encompassing glutamatergic/GABAergic transmission, neuromodulation
and the regulation of internal cell processes.
We conclude that we need to pursue integrated models of neural and synaptic
plasticity, which combine AMPA and glutamate related plasticity and NM
related plasticity into a single model. Fundamentally new theoretical abstrac-
tions need to be developed that can provide a guideline in the experimental
testing of their implications. Essentially we will have to explore the agonist-
dependence of NM receptor sensitivity and the concept of conditional plasticity
as the basis of ”learning rules” for neuromodulation (e.g., (156)).
Non-traditional sources of plasticity that may contribute to models of memo-
ry and learning are not restricted to plasticity in NM receptor activity. They
include long-term alterations of the distribution of ion channels, morpholog-
ical alterations in spine density and dendritic branching, and levels of gene
expression for a number of proteins affecting intracellular pathways.
The fundamental dogma of Hebbian plasticity - associative strengthening of
the synaptic connections that mediate fast neural transmission as neural sub-
strate for learning - may have to be reconsidered.
The modification of synaptic connections has undoubtedly a major role in
experience-dependent plasticity - but the idea of associative strengthening
based on the co-occurence (or, in more modern views, the precise timing) of
pre- and postsynaptic activity may have to be embedded in a more compre-
hensive view, involving NM induced switching, overloading of synaptic values,
or adaptive regulation of coupling strength. In general, the processes that gov-
ern cross-signaling in transmitter release are not sufficiently understood, but
undoubtedly of importance in understanding synaptic plasticity, as well as
the interaction of NM receptors with glutamate and GABA receptors in the
postsynaptic domain.
But besides that, we may have to further investigate the role of whole-neuron
plasticity in learning and memorization. This involves the storage of experience
by cellular parameters and performing read-out by alteration of membrane
properties that affect the transfer function.
In the light of the major potential sources of cellular plasticity uncovered by
molecular biology, it may well be that the most significant models on the
neural substrate of behavioral learning and memorization are yet ahead of us.
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